1-(4-(3-chlorophenyl)piperazin-1-yl)-2-phenoxyethan-1-one | 1044-41-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 1-(4-(3-chlorophenyl)piperazin-1-yl)-2-phenoxyethan-1-one
• 英文别名: N-<3-Chlor-phenyl>-N'-phenoxyacetyl-piperazin；1-(3-Chlorophenyl)-4-(phenoxyacetyl)piperazine；1-[4-(3-chlorophenyl)piperazin-1-yl]-2-phenoxyethanone
• CAS: 1044-41-3
• 化学式: C₁₈H₁₉ClN₂O₂
• mdl: MFCD01107152
• 分子量: 330.814
• InChiKey: LWXOZDNTPSWODA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  32.8
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS<br/>[FR] INHIBITEURS DOUBLES DE NAV1.2/5HT2A POUR TRAITER DES TROUBLES DU SNC
  申请人：SUNOVION PHARMACEUTICALS INC

  公开号：WO2018026371A1

  公开（公告）日：2018-02-08

  Compounds of formula I: I are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.

  公开了化学式I的化合物，以及含有这些化合物的药物组合物。还公开了治疗患有神经系统或精神障碍的患者的方法。这些障碍包括抑郁症、躁郁症、疼痛、精神分裂症、强迫症、成瘾、社交障碍、注意力缺陷多动障碍、焦虑障碍、自闭症、认知障碍，或神经精神症状，如冷漠、抑郁、焦虑、精神病、攻击性、激动、冲动控制障碍，以及在神经系统疾病如阿尔茨海默病和帕金森病中的睡眠障碍。
• N-substituted piperazines
  申请人：Lorsbach Anne Beth

  公开号：US20070004750A1

  公开（公告）日：2007-01-04

  Novel N-alkyl substituted piperazines have been discovered, which are useful as insecticides or fungicides. Such compounds are of Formula (I) wherein X, Y, R1 and R2 are as defined herein.

  已发现新型N-烷基取代哌嗪，可用作杀虫剂或杀菌剂。这些化合物的化学式为（I），其中X、Y、R1和R2如本文所定义。
• N-SUBSTITUTED PIPERAZINES
  申请人：Lorsbach Beth Anne

  公开号：US20100234391A1

  公开（公告）日：2010-09-16

  Novel N-alkyl substituted piperazines have been discovered, which are useful as insecticides or fungicides. Such compounds are of Formula (I) wherein X, Y, R1 and R2 are as defined herein.

  已经发现了新型的N-烷基取代哌嗪类化合物，可用作杀虫剂或杀菌剂。此类化合物的化学式为（I），其中X、Y、R1和R2的定义如下。
• N- SUBSTITUTED PIPERAZINES
  申请人：Dow AgroSciences LLC

  公开号：US20130072497A1

  公开（公告）日：2013-03-21

  Novel N-alkyl substituted piperazines have been discovered, which are useful as insecticides or fungicides. Such compounds are of Formula (I) wherein X, Y, R1 and R2 are as defined herein.

  已经发现了新型的N-烷基取代哌嗪，可用作杀虫剂或杀菌剂。此类化合物的化学式为（I），其中X、Y、R1和R2的定义如下。
• Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
  申请人：Sunovion Pharmaceuticals Inc.

  公开号：US11186564B2

  公开（公告）日：2021-11-30

  Compounds of formula I: are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.

  式 I 的化合物： 以及含有此类化合物的药物组合物。还公开了治疗有需要的患者的神经或精神障碍的方法。此类疾病包括抑郁症、双相情感障碍、疼痛、精神分裂症、强迫症、成瘾症、社交障碍、注意力缺陷多动障碍、焦虑症、自闭症、认知障碍或神经精神症状，如冷漠、抑郁、焦虑、精神病、攻击性、激动、冲动控制障碍，以及神经系统疾病如阿尔茨海默病和帕金森病的睡眠障碍。